Whole genome sequencing is unlikely to become a routine part of medicine anytime soon.   In this era of plummeting DNA sequencing costs, we frequently hear the claim that soon everyone should have their whole genome sequenced. However, two implicit assumptions underlie such claims... [More]

With whole genome sequencing (WGS) quickly becoming more affordable and accessible, debates are quickly turning to how such next generation technologies will be integrated into clinical care and how and under what circumstances they will benefit patients and the greater public good.   &... [More]

The National Institutes of Health is seeking proposals for research projects on the implications of information obtained from sequencing the genome to identify diseases in newborns. The intent of funding such projects is to further the understanding of disorders that appear during the newborn pe... [More]

With sharp declines in the cost of whole genome sequencing, the day of accurately deciphering disease risk based on an individual's genome may seem at hand. But a study involving data of thousands of identical twins by Johns Hopkins investigators finds that genomic fortune-telling fails to provi... [More]